APPB Stock Overview
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Applied Biosciences Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.10 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.86% |
| 5 Year Change | -99.98% |
| Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| APPB | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.08% | 1.2% |
| 1Y | n/a | 13.2% | 24.9% |
Return vs Industry: Insufficient data to determine how APPB performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how APPB performed against the US Market.
Price Volatility
| APPB volatility | |
|---|---|
| APPB Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: APPB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine APPB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | n/a | www.appliedbiocorp.com |
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.
Applied Biosciences Corp. Fundamentals Summary
| APPB fundamental statistics | |
|---|---|
| Market cap | US$4.28k |
| Earnings (TTM) | -US$2.79m |
| Revenue (TTM) | US$859.86k |
0.0x
P/S Ratio0.0x
P/E RatioIs APPB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APPB income statement (TTM) | |
|---|---|
| Revenue | US$859.86k |
| Cost of Revenue | US$331.55k |
| Gross Profit | US$528.31k |
| Other Expenses | US$3.31m |
| Earnings | -US$2.79m |
Last Reported Earnings
Dec 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did APPB perform over the long term?
See historical performance and comparison